Cited by 165Tissue Engineering and Regenerative MedicinePluripotent Stem Cells Research3D Printing in Biomedical Research

Development of a Three-Dimensional Bioengineering Technology to Generate Lung Tissue for Personalized Disease Modeling

Open access
Wilkinson, Dan C., Alva-Ornelas, Jackelyn A., Sucre, Jennifer M.S., Vijayaraj, Preethi, Durra, Abdo, Richardson, Wade, Jonas, Steven J., Paul, Manash K. +3 more·2017·Stem Cells Translational Medicine

Abstract

Stem cell technologies, especially patient-specific, induced stem cell pluripotency and directed differentiation, hold great promise for changing the landscape of medical therapies. Proper exploitation of these methods may lead to personalized organ transplants, but to regenerate organs, it is necessary to develop methods for assembling differentiated cells into functional, organ-level tissues. The generation of three-dimensional human tissue models also holds potential for medical advances in disease modeling, as full organ functionality may not be necessary to recapitulate disease pathophysiology. This is specifically true of lung diseases where animal models often do not recapitulate human disease. Here, we present a method for the generation of self-assembled human lung tissue and its potential for disease modeling and drug discovery for lung diseases characterized by progressive and irreversible scarring such as idiopathic pulmonary fibrosis (IPF). Tissue formation occurs because of the overlapping processes of cellular adhesion to multiple alveolar sac templates, bioreactor rotation, and cellular contraction. Addition of transforming growth factor-β1 to single cell-type mesenchymal organoids resulted in morphologic scarring typical of that seen in IPF but not in two-dimensional IPF fibroblast cultures. Furthermore, this lung organoid may be modified to contain multiple lung cell types assembled into the correct anatomical location, thereby allowing cell-cell contact and recapitulating the lung microenvironment. Our bottom-up approach for synthesizing patient-specific lung tissue in a scalable system allows for the development of relevant human lung disease models with the potential for high throughput drug screening to identify targeted therapies.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5966/sctm.2016-0192

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Organoid types grown in alginate include human lung, human brain, murine intestinal, human intestinal, human pancreatic, and human and murine vascular.

    “Organoid types grown in alginate include human lung99,100, human brain101, murine intestinal102, human intestinal102,103, human pancreatic104, and human and murine vascular105.”

    From Towards organoid culture without Matrigel (2021) · cites this paper as [99]

  • Several laboratories have grown a wide range of organoids in polysaccharides such as alginate or alginate-chitosan mixtures.

    “In addition to organoids grown in naturally-derived proteins, several laboratories have grown a wide range of organoids in polysaccharides such as alginate or alginate-chitosan mixtures.”

    From Towards organoid culture without Matrigel (2021) · cites this paper as [99]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. [23]Samuel CS. Kidney research. In: Hewitson TD, Becker GJ, eds. Methods in Molecular Biology 2009;Vol 466 Totowa, NJ: Humana Press 223– 235.

Cited by

Sorted by citations

Authors
Wilkinson, D. C., Alva-Ornelas, J. A., Sucre, J. M. S., Vijayaraj, P., Durra, A., Richardson, W., Jonas, S. J., Paul, M. K., Karumbayaram, S., Dunn, B., & Gomperts, B. N.
Affiliations
University of California, Los Angeles (US)
Corresponding author
Gomperts, Brigitte N.
Venue
Stem Cells Translational Medicine
Published
2016-09-15
Volume
6
Issue
2
Pages
622-633
ISSN
  • 2157-6564 (ISSN-L)
  • 2157-6580
OpenAlex
W2520176498
Cited by
165
References
36
Citations by year
2026: 5 · 2025: 17 · 2024: 11 · 2023: 21 · 2022: 28 · 2021: 24 · 2020: 14 · 2019: 8 · 2018: 19 · 2017: 15 · 2016: 2
FWCI
16.24
Type
journal article
Language
en
Open access
Locations
  • Stem Cells Translational Medicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • eScholarship (California Digital Library) (submittedVersion)
Funders
  • National Science Foundation
  • California Institute for Regenerative Medicine (12-02)
  • National Institutes of Health
  • University of California, Los Angeles
  • National Institute of General Medical Sciences (GM114259-01, R01GM114259)
  • Jonsson Comprehensive Cancer Center
  • Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research, University of California Los Angeles
Topics
  • Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
Keywords
lung organoids, idiopathic pulmonary fibrosis, disease modeling, TGF-β1, fibrosis, drug screening, personalized medicine, organ regeneration
MeSH terms
Cell Differentiation, Cells, Cultured, Fibroblasts, Humans, Lung, Organoids, Phenotype, Time Factors, Cell Culture Techniques, Cell Lineage, Bioreactors, Tissue Engineering, Transforming Growth Factor beta1, Idiopathic Pulmonary Fibrosis, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review